Industry Research Reports

Home > Reports > Medical Care > CRISPR Gene Editing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

CRISPR Gene Editing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 103 Pages

Report ld: 2625588

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

CRISPR gene editing is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified.

The global market for CRISPR Gene Editing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for CRISPR Gene Editing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CRISPR Gene Editing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for CRISPR Gene Editing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of CRISPR Gene Editing include Abcam, Inc., Applied StemCell, Inc., Cellecta, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc. and Merck KGaA, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Editing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CRISPR Gene Editing by region & country, by Type, and by Application.

The CRISPR Gene Editing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Editing.

Market Segmentation

Report Metric
Details
Report Title
CRISPR Gene Editing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global CRISPR Gene Editing Companies Covered
Abcam, Inc., Applied StemCell, Inc., Cellecta, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs, Inc.
Global CRISPR Gene Editing Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRISPR Gene Editing Market, Segment by Type
gRNA Design and Vector Construction

Cell Line and Engineering

Screening Services

Others
Global CRISPR Gene Editing Market, Segment by Application
Agricultural

Biomedical

Industrial

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CRISPR Gene Editing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CRISPR Gene Editing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CRISPR Gene Editing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 CRISPR Gene Editing Product Introduction
    1.2 Global CRISPR Gene Editing Market Size Forecast
    1.3 CRISPR Gene Editing Market Trends & Drivers
        1.3.1 CRISPR Gene Editing Industry Trends
        1.3.2 CRISPR Gene Editing Market Drivers & Opportunity
        1.3.3 CRISPR Gene Editing Market Challenges
        1.3.4 CRISPR Gene Editing Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global CRISPR Gene Editing Players Revenue Ranking (2023)
    2.2 Global CRISPR Gene Editing Revenue by Company (2019-2024)
    2.3 Key Companies CRISPR Gene Editing Manufacturing Base Distribution and Headquarters
    2.4 Key Companies CRISPR Gene Editing Product Offered
    2.5 Key Companies Time to Begin Mass Production of CRISPR Gene Editing
    2.6 CRISPR Gene Editing Market Competitive Analysis
        2.6.1 CRISPR Gene Editing Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by CRISPR Gene Editing Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Editing as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 gRNA Design and Vector Construction
        3.1.2 Cell Line and Engineering
        3.1.3 Screening Services
        3.1.4 Others
    3.2 Global CRISPR Gene Editing Sales Value by Type
        3.2.1 Global CRISPR Gene Editing Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global CRISPR Gene Editing Sales Value, by Type (2019-2030)
        3.2.3 Global CRISPR Gene Editing Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Agricultural
        4.1.2 Biomedical
        4.1.3 Industrial
        4.1.4 Others
    4.2 Global CRISPR Gene Editing Sales Value by Application
        4.2.1 Global CRISPR Gene Editing Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global CRISPR Gene Editing Sales Value, by Application (2019-2030)
        4.2.3 Global CRISPR Gene Editing Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global CRISPR Gene Editing Sales Value by Region
        5.1.1 Global CRISPR Gene Editing Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global CRISPR Gene Editing Sales Value by Region (2019-2024)
        5.1.3 Global CRISPR Gene Editing Sales Value by Region (2025-2030)
        5.1.4 Global CRISPR Gene Editing Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America CRISPR Gene Editing Sales Value, 2019-2030
        5.2.2 North America CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe CRISPR Gene Editing Sales Value, 2019-2030
        5.3.2 Europe CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific CRISPR Gene Editing Sales Value, 2019-2030
        5.4.2 Asia Pacific CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America CRISPR Gene Editing Sales Value, 2019-2030
        5.5.2 South America CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa CRISPR Gene Editing Sales Value, 2019-2030
        5.6.2 Middle East & Africa CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions CRISPR Gene Editing Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions CRISPR Gene Editing Sales Value
    6.3 United States
        6.3.1 United States CRISPR Gene Editing Sales Value, 2019-2030
        6.3.2 United States CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States CRISPR Gene Editing Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe CRISPR Gene Editing Sales Value, 2019-2030
        6.4.2 Europe CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe CRISPR Gene Editing Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China CRISPR Gene Editing Sales Value, 2019-2030
        6.5.2 China CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.5.3 China CRISPR Gene Editing Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan CRISPR Gene Editing Sales Value, 2019-2030
        6.6.2 Japan CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan CRISPR Gene Editing Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea CRISPR Gene Editing Sales Value, 2019-2030
        6.7.2 South Korea CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea CRISPR Gene Editing Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia CRISPR Gene Editing Sales Value, 2019-2030
        6.8.2 Southeast Asia CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia CRISPR Gene Editing Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India CRISPR Gene Editing Sales Value, 2019-2030
        6.9.2 India CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
        6.9.3 India CRISPR Gene Editing Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abcam, Inc.
        7.1.1 Abcam, Inc. Profile
        7.1.2 Abcam, Inc. Main Business
        7.1.3 Abcam, Inc. CRISPR Gene Editing Products, Services and Solutions
        7.1.4 Abcam, Inc. CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.1.5 Abcam, Inc. Recent Developments
    7.2 Applied StemCell, Inc.
        7.2.1 Applied StemCell, Inc. Profile
        7.2.2 Applied StemCell, Inc. Main Business
        7.2.3 Applied StemCell, Inc. CRISPR Gene Editing Products, Services and Solutions
        7.2.4 Applied StemCell, Inc. CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.2.5 Applied StemCell, Inc. Recent Developments
    7.3 Cellecta, Inc.
        7.3.1 Cellecta, Inc. Profile
        7.3.2 Cellecta, Inc. Main Business
        7.3.3 Cellecta, Inc. CRISPR Gene Editing Products, Services and Solutions
        7.3.4 Cellecta, Inc. CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.3.5 CRISPR Therapeutics AG Recent Developments
    7.4 CRISPR Therapeutics AG
        7.4.1 CRISPR Therapeutics AG Profile
        7.4.2 CRISPR Therapeutics AG Main Business
        7.4.3 CRISPR Therapeutics AG CRISPR Gene Editing Products, Services and Solutions
        7.4.4 CRISPR Therapeutics AG CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.4.5 CRISPR Therapeutics AG Recent Developments
    7.5 GeneCopoeia, Inc.
        7.5.1 GeneCopoeia, Inc. Profile
        7.5.2 GeneCopoeia, Inc. Main Business
        7.5.3 GeneCopoeia, Inc. CRISPR Gene Editing Products, Services and Solutions
        7.5.4 GeneCopoeia, Inc. CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.5.5 GeneCopoeia, Inc. Recent Developments
    7.6 GenScript Biotech Corporation
        7.6.1 GenScript Biotech Corporation Profile
        7.6.2 GenScript Biotech Corporation Main Business
        7.6.3 GenScript Biotech Corporation CRISPR Gene Editing Products, Services and Solutions
        7.6.4 GenScript Biotech Corporation CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.6.5 GenScript Biotech Corporation Recent Developments
    7.7 Horizon Discovery Group PLC
        7.7.1 Horizon Discovery Group PLC Profile
        7.7.2 Horizon Discovery Group PLC Main Business
        7.7.3 Horizon Discovery Group PLC CRISPR Gene Editing Products, Services and Solutions
        7.7.4 Horizon Discovery Group PLC CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.7.5 Horizon Discovery Group PLC Recent Developments
    7.8 Integrated DNA Technologies, Inc.
        7.8.1 Integrated DNA Technologies, Inc. Profile
        7.8.2 Integrated DNA Technologies, Inc. Main Business
        7.8.3 Integrated DNA Technologies, Inc. CRISPR Gene Editing Products, Services and Solutions
        7.8.4 Integrated DNA Technologies, Inc. CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.8.5 Integrated DNA Technologies, Inc. Recent Developments
    7.9 Merck KGaA
        7.9.1 Merck KGaA Profile
        7.9.2 Merck KGaA Main Business
        7.9.3 Merck KGaA CRISPR Gene Editing Products, Services and Solutions
        7.9.4 Merck KGaA CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.9.5 Merck KGaA Recent Developments
    7.10 New England Biolabs, Inc.
        7.10.1 New England Biolabs, Inc. Profile
        7.10.2 New England Biolabs, Inc. Main Business
        7.10.3 New England Biolabs, Inc. CRISPR Gene Editing Products, Services and Solutions
        7.10.4 New England Biolabs, Inc. CRISPR Gene Editing Revenue (US$ Million) & (2019-2024)
        7.10.5 New England Biolabs, Inc. Recent Developments

 8 Industry Chain Analysis
    8.1 CRISPR Gene Editing Industrial Chain
    8.2 CRISPR Gene Editing Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 CRISPR Gene Editing Sales Model
        8.5.2 Sales Channel
        8.5.3 CRISPR Gene Editing Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. CRISPR Gene Editing Market Trends
    Table 2. CRISPR Gene Editing Market Drivers & Opportunity
    Table 3. CRISPR Gene Editing Market Challenges
    Table 4. CRISPR Gene Editing Market Restraints
    Table 5. Global CRISPR Gene Editing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global CRISPR Gene Editing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies CRISPR Gene Editing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies CRISPR Gene Editing Product Type
    Table 9. Key Companies Time to Begin Mass Production of CRISPR Gene Editing
    Table 10. Global CRISPR Gene Editing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Editing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global CRISPR Gene Editing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global CRISPR Gene Editing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global CRISPR Gene Editing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global CRISPR Gene Editing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global CRISPR Gene Editing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global CRISPR Gene Editing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global CRISPR Gene Editing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global CRISPR Gene Editing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global CRISPR Gene Editing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global CRISPR Gene Editing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global CRISPR Gene Editing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global CRISPR Gene Editing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global CRISPR Gene Editing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global CRISPR Gene Editing Sales Value by Region (2019-2024) & (%)
    Table 27. Global CRISPR Gene Editing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions CRISPR Gene Editing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions CRISPR Gene Editing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions CRISPR Gene Editing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abcam, Inc. Basic Information List
    Table 32. Abcam, Inc. Description and Business Overview
    Table 33. Abcam, Inc. CRISPR Gene Editing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in CRISPR Gene Editing Business of Abcam, Inc. (2019-2024)
    Table 35. Abcam, Inc. Recent Developments
    Table 36. Applied StemCell, Inc. Basic Information List
    Table 37. Applied StemCell, Inc. Description and Business Overview
    Table 38. Applied StemCell, Inc. CRISPR Gene Editing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in CRISPR Gene Editing Business of Applied StemCell, Inc. (2019-2024)
    Table 40. Applied StemCell, Inc. Recent Developments
    Table 41. Cellecta, Inc. Basic Information List
    Table 42. Cellecta, Inc. Description and Business Overview
    Table 43. Cellecta, Inc. CRISPR Gene Editing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in CRISPR Gene Editing Business of Cellecta, Inc. (2019-2024)
    Table 45. Cellecta, Inc. Recent Developments
    Table 46. CRISPR Therapeutics AG Basic Information List
    Table 47. CRISPR Therapeutics AG Description and Business Overview
    Table 48. CRISPR Therapeutics AG CRISPR Gene Editing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in CRISPR Gene Editing Business of CRISPR Therapeutics AG (2019-2024)
    Table 50. CRISPR Therapeutics AG Recent Developments
    Table 51. GeneCopoeia, Inc. Basic Information List
    Table 52. GeneCopoeia, Inc. Description and Business Overview
    Table 53. GeneCopoeia, Inc. CRISPR Gene Editing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in CRISPR Gene Editing Business of GeneCopoeia, Inc. (2019-2024)
    Table 55. GeneCopoeia, Inc. Recent Developments
    Table 56. GenScript Biotech Corporation Basic Information List
    Table 57. GenScript Biotech Corporation Description and Business Overview
    Table 58. GenScript Biotech Corporation CRISPR Gene Editing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in CRISPR Gene Editing Business of GenScript Biotech Corporation (2019-2024)
    Table 60. GenScript Biotech Corporation Recent Developments
    Table 61. Horizon Discovery Group PLC Basic Information List
    Table 62. Horizon Discovery Group PLC Description and Business Overview
    Table 63. Horizon Discovery Group PLC CRISPR Gene Editing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in CRISPR Gene Editing Business of Horizon Discovery Group PLC (2019-2024)
    Table 65. Horizon Discovery Group PLC Recent Developments
    Table 66. Integrated DNA Technologies, Inc. Basic Information List
    Table 67. Integrated DNA Technologies, Inc. Description and Business Overview
    Table 68. Integrated DNA Technologies, Inc. CRISPR Gene Editing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in CRISPR Gene Editing Business of Integrated DNA Technologies, Inc. (2019-2024)
    Table 70. Integrated DNA Technologies, Inc. Recent Developments
    Table 71. Merck KGaA Basic Information List
    Table 72. Merck KGaA Description and Business Overview
    Table 73. Merck KGaA CRISPR Gene Editing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in CRISPR Gene Editing Business of Merck KGaA (2019-2024)
    Table 75. Merck KGaA Recent Developments
    Table 76. New England Biolabs, Inc. Basic Information List
    Table 77. New England Biolabs, Inc. Description and Business Overview
    Table 78. New England Biolabs, Inc. CRISPR Gene Editing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in CRISPR Gene Editing Business of New England Biolabs, Inc. (2019-2024)
    Table 80. New England Biolabs, Inc. Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. CRISPR Gene Editing Downstream Customers
    Table 84. CRISPR Gene Editing Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. CRISPR Gene Editing Product Picture
    Figure 2. Global CRISPR Gene Editing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global CRISPR Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 4. CRISPR Gene Editing Report Years Considered
    Figure 5. Global CRISPR Gene Editing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by CRISPR Gene Editing Revenue in 2023
    Figure 7. CRISPR Gene Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. gRNA Design and Vector Construction Picture
    Figure 9. Cell Line and Engineering Picture
    Figure 10. Screening Services Picture
    Figure 11. Others Picture
    Figure 12. Global CRISPR Gene Editing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global CRISPR Gene Editing Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Agricultural
    Figure 15. Product Picture of Biomedical
    Figure 16. Product Picture of Industrial
    Figure 17. Product Picture of Others
    Figure 18. Global CRISPR Gene Editing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global CRISPR Gene Editing Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America CRISPR Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe CRISPR Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific CRISPR Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America CRISPR Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa CRISPR Gene Editing Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa CRISPR Gene Editing Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions CRISPR Gene Editing Sales Value (%), (2019-2030)
    Figure 31. United States CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 37. China CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 39. China CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 49. India CRISPR Gene Editing Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India CRISPR Gene Editing Sales Value by Type (%), 2023 VS 2030
    Figure 51. India CRISPR Gene Editing Sales Value by Application (%), 2023 VS 2030
    Figure 52. CRISPR Gene Editing Industrial Chain
    Figure 53. CRISPR Gene Editing Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

CRISPR gene editing is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified.

The global market for CRISPR Gene Editing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for CRISPR Gene Editing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CRISPR Gene Editing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for CRISPR Gene Editing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation